Navigating Long-Term Success & Transformation Reaching the one-year milestone after bariatric surgery is a major achievement in your journey toward better health. About 12 months after surgery, patients often experience…
June 23 , 2025 | 6 Minutes to Read
What to Watch Out For and How to Avoid Them for Long-Term Success Bariatric surgery is an incredibly powerful tool for weight loss and a significant step towards improved health. However, the procedure itself is just the beginning of a lifelong journey. The…
May 8 , 2025 | 3 Minutes to Read
Introduction: The ongoing debate in weight loss treatments In the battle against obesity, two major treatments have gained significant attention—bariatric surgery and GLP-1 receptor agonist (GLP-1 RA) medications. A recent systematic review has found that weight loss from bariatric surgery is more effective…
March 26 , 2025 | 5 Minutes to Read
In the ever-evolving landscape of medical technology, robotics has emerged as a game-changer in various fields of surgery. In recent years, the field of bariatric surgery has witnessed a significant rise in the adoption of robotic systems, particularly for procedures like sleeve gastrectomy…
March 3 , 2025 | 3 Minutes to Read
The hidden dangers of weight loss drugs: New study links Ozempic to vision loss In the pursuit of rapid weight loss, many adults have turned to GLP-1 medications like Ozempic, Wegovy, and Mounjaro. However, a shocking new study published in JAMA Ophthalmology has…
March 3 , 2025 | 4 Minutes to Read
Few medications have experienced a rise as meteoric as semaglutide (Ozempic, Wegovy) and tirzepatide (Zepbound), the GLP-1-based treatments for obesity that have captivated society and quickly become household names. These drugs represent a significant advancement in obesity medicine. Until semaglutide’s 2021 FDA approval…
February 15 , 2025 | 4 Minutes to Read
The GLP-1 Dilemma Why Many Quit Weight Loss and Diabetes Drugs Such As Ozempic, Wegovy and Mounjarro Within a Year? A growing number of people are turning to GLP-1 medications for weight loss and diabetes management, but research shows that most discontinue these…
December 27 , 2024 | 4 Minutes to Read
Over the past three decades, the rates of overweight and obesity in the United States have more than doubled, prompting experts to sound the alarm. By 2050, it’s estimated that 213 million adults and 43 million children and adolescents in the U.S. will…
December 23 , 2024 | 3 Minutes to Read
GLP-1 receptor agonists (GLP-1 RAs) are often marketed as breakthrough solutions for weight loss and Type 2 diabetes management. However, a closer look reveals that these medications frequently fail to live up to the hype. With rebound weight gain, high costs, and potential…
November 19 , 2024 | 5 Minutes to Read
What are GLP-1 agonists? GLP-1 agonists, or Glucagon-Like Peptide-1 receptor agonists, are medications primarily prescribed for managing type 2 diabetes (HbA1c), certain cardiovascular risks in people with type 2 diabetes and, more recently, obesity. They work by mimicking GLP-1, a natural hormone in…
Be inspired by more success stories than you can count. Share your challenges, goals and successes with Perth Bariatrics Support Group today!
Learn more about how to make the best of your weight loss journey from our newsletter!
